MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 07.11.2025
Catalyst Biosciences Kurshistorie 2011-2025 | CBIO
Kurshistorie Jährlich Catalyst Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.51 | 0.2 | 0.91 | 6.31 | 6.81 | 7.89 | 13.6 | 9.75 | 47 | 205 | 324 | 341 | 434 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 434 | 0.2 | 107 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M |  USA |
 |
AbbVie
ABBV
|
194 | $ 223.98 | -0.53 % | $ 396 B | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
2.68 | $ 4.67 | 1.74 % | $ 775 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
1.97 | $ 3.36 | 2.75 % | $ 260 M | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 210.16 | 4.43 % | $ 5 B |  Danmark |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M |  Israel |
 |
Aptorum Group Limited
APM
|
0.75 | $ 1.33 | -1.48 % | $ 7.25 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.42 | 2.09 % | $ 8.23 B |  Australia |
 |
Amphastar Pharmaceuticals
AMPH
|
27 | $ 25.9 | 0.74 % | $ 1.25 B | USA |
 |
AstraZeneca PLC
AZN
|
74.2 | $ 90.29 | - | $ 96.9 B | Britain |
 |
Anika Therapeutics
ANIK
|
25.4 | $ 9.49 | - | $ 139 M | USA |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.28 | - | $ 14.3 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
Biogen
BIIB
|
133 | $ 172.5 | - | $ 25.1 B | USA |
 |
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Benitec Biopharma
BNTC
|
13.5 | $ 12.96 | 1.17 % | $ 533 M | USA |
 |
ChromaDex Corporation
CDXC
|
5.67 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
526 | $ 581.03 | 2.22 % | $ 44 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 0.29 | -0.31 % | $ 631 M | Israel |
 |
Checkpoint Therapeutics
CKPT
|
4.04 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.43 | - | -16.75 % | $ 25.8 M | USA |
 |
Clovis Oncology
CLVS
|
2.04 | - | -7.23 % | $ 13 M | USA |
 |
Cerus Corporation
CERS
|
1.63 | $ 2.15 | 13.76 % | $ 397 M | USA |
 |
BioVie
BIVI
|
1.65 | $ 1.51 | -4.43 % | $ 2.23 M | USA |
 |
Cortexyme
CRTX
|
1.88 | - | -1.05 % | $ 67.1 M | USA |
 |
Celldex Therapeutics
CLDX
|
20.4 | $ 27.94 | - | $ 1.8 M | USA |
 |
Cellectar Biosciences
CLRB
|
3.64 | $ 3.78 | -5.97 % | $ 46.2 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
14.1 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
133 | $ 11.44 | 7.92 % | $ 740 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 96.0 | - | $ 27.2 B |  Germany |
 |
Eloxx Pharmaceuticals
ELOX
|
2.84 | - | -5.68 % | $ 8.28 M | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Enochian Biosciences
ENOB
|
0.7 | - | - | $ 40.5 M | USA |
 |
Epizyme
EPZM
|
1.23 | - | - | $ 249 M | USA |